+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Life Science Tools - Global Strategic Business Report

  • PDF Icon

    Report

  • 849 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302818
The global market for Life Science Tools is estimated at US$151.2 Billion in 2023 and is projected to reach US$264.6 Billion by 2030, growing at a CAGR of 8.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the life science tools market is driven by several factors, including the increasing demand for personalized medicine, rising investments in research and development, and advancements in technology. Personalized medicine, which tailors treatments to individual genetic profiles, relies heavily on genomic and proteomic tools, driving demand in these areas. Significant funding from government bodies, private organizations, and venture capitalists is fueling research initiatives and the development of new tools. Technological advancements, such as the development of AI and machine learning algorithms, are enhancing data analysis capabilities and speeding up the discovery process. The growing prevalence of chronic diseases and the need for innovative diagnostic and therapeutic solutions are also key drivers. Furthermore, the expansion of biotechnology and pharmaceutical industries, coupled with the increasing adoption of life science tools in emerging markets, is contributing to market growth. As these tools become more accessible and integrated into various research and clinical applications, their impact on health and disease management continues to grow, propelling further advancements in the field.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cell Biology Technology segment, which is expected to reach US$84.6 Billion by 2030 with a CAGR of a 7.4%. The Genomics Technology segment is also set to grow at 8.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $53.5 Billion in 2023, and China, forecasted to grow at an impressive 12.5% CAGR to reach $31.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Life Science Tools Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Life Science Tools Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Life Science Tools Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 295 Featured):

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • A Prelude to Life Sciences Tools
  • Global Economic Update
  • Competition
  • Players Pursue Product Launch & Innovation to Stay Relevant in Competitive Life Science Tools Market
  • Life Science Tools - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Market Analysis and Prospects
  • Global Life Science Tools Market Appears Primed for Healthy Growth Ahead
  • Cell Biology Holds Significant Revenue Stake
  • Hospitals Remain Primary End-User Segment
  • North America Maintains Front Rank in Global Life Science Tools Market
  • Asia-Pacific to Exhibit Impressive Growth
  • Salient Drivers Keeping Global Life Science Tools Market in Good Shape
  • Technology Trends in the Life Sciences Domain
  • Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
  • Exponential Intelligence, Quantum Computing and Ambient Technologies to Make Headway
  • Cloud Platforms Ease Data Sharing
  • Life Sciences to Gain with Blockchain Edge
  • AI-enabled Automation to Deliver Tangible Benefits for All
  • Cybersecurity Needs Grow for Life Sciences
  • Intertwined Factors with Major Implications for Life Science Domain & Related Tools
  • Recent Market Activity
  • World Brands
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Trends in Life Science Sector Support Demand
  • Why Diagnostic Testing is Key to Mitigate Impact of Infectious Diseases?
  • 3D Cell Culture Transforms Life Sciences Industry
  • Global 3D Cell Culture Market in US$ Million: 2020 - 2027
  • Increasing Demand for 3D Cell Culture in Drug Discovery
  • Use of 3D Cell Culture for Regenerative Medicine
  • mRNA Technology Gains Spotlight in Life Sciences
  • Innovations in Instrumentation Expand Functionality and Drive Adoption of PCR
  • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
  • Global qPCR and dPCR Instrumentation Market in US$ Million: 2020-2025
  • Genome Sequencing Experiences Host of Evolutionary Waves
  • Greater Integration of Genomic Technologies in the Development of Novel Diagnostics Tests
  • Next Generation Sequencing Drives the Market Growth
  • R&D Activity Remains Vibrant in NGS
  • The Need for Large-scale NGS Data Analysis Pushes for Cloud-enabled Bioinformatics Services
  • Single-Cell Spatial Biology Technologies Poised to Emerge as an Integral Aspect of Future Labs
  • Rising Application of Whole Genome Sequencing Drives Demand for Faster Secondary Analysis Tools
  • Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects
  • Global BioPharmaceuticals Market in US$ Billion: 2020 and 2026
  • Liquid Chromatography Drives Growth in New Application Markets
  • Innovative HPLC Products Inject New Growth
  • Digital Transformation of Life Sciences Sector Improves Efficiency and Productivity
  • Key Initiators of Digital Transformation in Life Sciences
  • Artificial Intelligence offers Multiple Opportunities
  • Wearable Devices Gains Popularity
  • The Cloud Technology Witnesses Rapid Growth
  • VR and E-pharmacy
  • Smart Quality
  • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
  • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
  • Technological Developments and Expanding End-Use Applications to Bolster Growth in Mass Spectrometry
  • Global Chromatography Market (2022): Percentage Share Breakdown of Value Sales by Chromatography Techniques
  • Miniature Mass Spectroscopy Instruments Get Popular
  • Increase in Healthcare Spending to Propel Demand for Life Science Tools
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • The Rise of Data Analytics in Life Sciences
  • Data Science in Drug R&D
  • Data Sharing Emerges as a Significant Trend to Gain Competitive Advantage
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Life Science Tools Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Government & Academics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
GERMANY
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPEASIA-PACIFICAUSTRALIA
INDIA
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICA
MIDDLE EAST
  • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
AFRICAIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

Table Information